Literature DB >> 22211964

Current models and strategies in the development of antiobesity drugs.

James S Kinsey-Jones1, Kevin G Murphy.   

Abstract

Animal models have enabled investigation of the complex mechanisms underlying energy homeostasis and, therefore, the development of antiobesity drugs.
© 2011 New York Academy of Sciences.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22211964     DOI： 10.1111/j.1749-6632.2011.06343.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


  4 in total

1.  Betatrophin provides a new insight into diabetes treatment and lipid metabolism (Review).

Authors:  Jin-Zhou Zhu; Chao-Hui Yu; You-Ming Li
Journal:  Biomed Rep       Date:  2014-05-20

2.  MNK1 and MNK2 mediate adverse effects of high-fat feeding in distinct ways.

Authors:  C E J Moore; J Pickford; F R Cagampang; R L Stead; S Tian; X Zhao; X Tang; C D Byrne; C G Proud
Journal:  Sci Rep       Date:  2016-04-18       Impact factor: 4.379

3.  Inhibition of gastric lipase as a mechanism for body weight and plasma lipids reduction in Zucker rats fed a rosemary extract rich in carnosic acid.

Authors:  María Romo Vaquero; María-Josefa Yáñez-Gascón; Rocío García Villalba; Mar Larrosa; Emilie Fromentin; Alvin Ibarra; Marc Roller; Francisco Tomás-Barberán; Juan Carlos Espín de Gea; María-Teresa García-Conesa
Journal:  PLoS One       Date:  2012-06-22       Impact factor: 3.240

Review 4.  Insulin-resistance-associated compensatory mechanisms of pancreatic Beta cells: a current opinion.

Authors:  Tiago G Araújo; Alexandre G Oliveira; Mario J A Saad
Journal:  Front Endocrinol (Lausanne)       Date:  2013-10-14       Impact factor: 5.555
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.